BACKGROUND: Contemporary prevalence of chronic kidney disease (CKD) and thrombotic cardiovascular (CV) events remains unclear in Veterans enrolled in the Veterans Affairs Health Care System (VA) care. Although oral P2Y12 inhibitors (P2Y12i) are increasingly being prescribed to this patient population, the overall prescription trend for P2Y12i remains unclear. METHODS: Using national VA corporate warehouse data, we used International Classification of Diseases-9 codes to identify Veterans with CKD, dialysis-dependent CKD, and CV events. VA pharmacy data were used to count P2Y12i prescriptions for the federal fiscal years (FY) 2011 through 2015. RESULTS: The period prevalence of Veterans with CKD was 378,233 (6.1%). The point prevalence of CKD increased by 49% from 132,979 (2.30%) in FY11 to 213,444 (3.42%) in FY15. The period prevalence of Veterans with dialysis-dependent CKD was 150,298 (2.4%). In all, 128,703 (56.7%) CV events occurred in Veterans with CKD. Veterans with CKD were given 50.1% of prescriptions for clopidogrel, 49.3% for prasugrel, and 60.4% for ticagrelor. In this patient population, year-to-year increases in P2Y12i prescriptions were observed with a dramatic increase in ticagrelor prescriptions. CONCLUSION: CKD is common among Veterans and its true prevalence is likely being underestimated. The prevalence of dialysis-dependent CKD is higher among Veterans than the non-Veteran US population. CV events are widely co-prevalent and these patients are commonly prescribed P2Y12i. The recent increase in ticagrelor prescriptions in this patient population and large cost differences between the 3 P2Y12i underline the need for future studies to identify the preferred P2Y12i for these patients. The Author(s). Published by S. Karger AG, Basel.
BACKGROUND: Contemporary prevalence of chronic kidney disease (CKD) and thrombotic cardiovascular (CV) events remains unclear in Veterans enrolled in the Veterans Affairs Health Care System (VA) care. Although oral P2Y12 inhibitors (P2Y12i) are increasingly being prescribed to this patient population, the overall prescription trend for P2Y12i remains unclear. METHODS: Using national VA corporate warehouse data, we used International Classification of Diseases-9 codes to identify Veterans with CKD, dialysis-dependent CKD, and CV events. VA pharmacy data were used to count P2Y12i prescriptions for the federal fiscal years (FY) 2011 through 2015. RESULTS: The period prevalence of Veterans with CKD was 378,233 (6.1%). The point prevalence of CKD increased by 49% from 132,979 (2.30%) in FY11 to 213,444 (3.42%) in FY15. The period prevalence of Veterans with dialysis-dependent CKD was 150,298 (2.4%). In all, 128,703 (56.7%) CV events occurred in Veterans with CKD. Veterans with CKD were given 50.1% of prescriptions for clopidogrel, 49.3% for prasugrel, and 60.4% for ticagrelor. In this patient population, year-to-year increases in P2Y12i prescriptions were observed with a dramatic increase in ticagrelor prescriptions. CONCLUSION: CKD is common among Veterans and its true prevalence is likely being underestimated. The prevalence of dialysis-dependent CKD is higher among Veterans than the non-Veteran US population. CV events are widely co-prevalent and these patients are commonly prescribed P2Y12i. The recent increase in ticagrelor prescriptions in this patient population and large cost differences between the 3 P2Y12i underline the need for future studies to identify the preferred P2Y12i for these patients. The Author(s). Published by S. Karger AG, Basel.
Authors: Robert M Califf; Melissa A Robb; Andrew B Bindman; Josephine P Briggs; Francis S Collins; Patrick H Conway; Trinka S Coster; Francesca E Cunningham; Nancy De Lew; Karen B DeSalvo; Christine Dymek; Victor J Dzau; Rachael L Fleurence; Richard G Frank; J Michael Gaziano; Petra Kaufmann; Michael Lauer; Peter W Marks; J Michael McGinnis; Chesley Richards; Joe V Selby; David J Shulkin; Jeffrey Shuren; Andrew M Slavitt; Scott R Smith; B Vindell Washington; P Jon White; Janet Woodcock; Jonathan Woodson; Rachel E Sherman Journal: N Engl J Med Date: 2016-12-15 Impact factor: 91.245
Authors: Kamyar Kalantar-Zadeh; Susan T Crowley; Srinivasan Beddhu; Joline L T Chen; John T Daugirdas; David S Goldfarb; Anna Jin; Csaba P Kovesdy; David J Leehey; Hamid Moradi; Sankar D Navaneethan; Keith C Norris; Yoshitsugu Obi; Ann O'Hare; Tariq Shafi; Elani Streja; Mark L Unruh; Tushar J Vachharajani; Steven Weisbord; Connie M Rhee Journal: Semin Dial Date: 2017-04-18 Impact factor: 3.455
Authors: Geoffrey D Barnes; Maggie A Stanislawski; Wenhui Liu; Anna E Barón; Ehrin J Armstrong; P Michael Ho; Andrew Klein; Thomas M Maddox; Brahmajee K Nallamothu; John S Rumsfeld; Thomas T Tsai; Steven M Bradley Journal: Circ Cardiovasc Qual Outcomes Date: 2016-05-31
Authors: Glenn N Levine; Eric R Bates; John A Bittl; Ralph G Brindis; Stephan D Fihn; Lee A Fleisher; Christopher B Granger; Richard A Lange; Michael J Mack; Laura Mauri; Roxana Mehran; Debabrata Mukherjee; L Kristin Newby; Patrick T O'Gara; Marc S Sabatine; Peter K Smith; Sidney C Smith Journal: Circulation Date: 2016-03-29 Impact factor: 29.690
Authors: Nishank Jain; Suman Kotla; Bertis B Little; Rick A Weideman; Emmanouil S Brilakis; Robert F Reilly; Subhash Banerjee Journal: Am J Cardiol Date: 2012-02-18 Impact factor: 2.778
Authors: Stefan James; Andrzej Budaj; Philip Aylward; Kristen K Buck; Christopher P Cannon; Jan H Cornel; Robert A Harrington; Jay Horrow; Hugo Katus; Matyas Keltai; Basil S Lewis; Keyur Parikh; Robert F Storey; Karolina Szummer; Daniel Wojdyla; Lars Wallentin Journal: Circulation Date: 2010-08-30 Impact factor: 29.690
Authors: Omar K Siddiqi; Kyle J Smoot; Alyssa B Dufour; Kelly Cho; Melissa Young; David R Gagnon; Samantha Ly; Sara Temiyasathit; David P Faxon; J Michael Gaziano; Scott Kinlay Journal: Heart Date: 2015-07-24 Impact factor: 5.994
Authors: Rebecca Gosling; Momina Yazdani; Yasir Parviz; Ian R Hall; Ever D Grech; Julian P Gunn; Robert F Storey; Javaid Iqbal Journal: Platelets Date: 2017-03-07 Impact factor: 3.862
Authors: Virginia Wang; Matthew L Maciejewski; Uptal D Patel; Karen M Stechuchak; Denise M Hynes; Morris Weinberger Journal: BMC Health Serv Res Date: 2013-01-18 Impact factor: 2.655
Authors: Andrea M Easom; Ashutosh M Shukla; Dumitru Rotaru; Songthip Ounpraseuth; Sudhir V Shah; John M Arthur; Manisha Singh Journal: Clin Kidney J Date: 2019-08-22
Authors: Nishank Jain; Suzanne L Hunt; Huizhong Cui; Milind A Phadnis; Jonathan D Mahnken; Theresa I Shireman; Junqiang Dai; Jawahar L Mehta; Rafia S Rasu Journal: Cardiovasc Drugs Ther Date: 2019-10 Impact factor: 3.727
Authors: Barbara E Jones; Jian Ying; Mckenna R Nevers; Patrick R Alba; Olga V Patterson; Kelly S Peterson; Elizabeth Rutter; Matthew A Christensen; Sarah Stern; Makoto M Jones; Adi Gundlapalli; Nathan C Dean; Matthew C Samore; Tome Greene Journal: J Gen Intern Med Date: 2022-03-09 Impact factor: 5.128